Literature DB >> 23737423

The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons.

Pim Cuijpers1, Marit Sijbrandij, Sander L Koole, Gerhard Andersson, Aartjan T Beekman, Charles F Reynolds.   

Abstract

Although psychotherapy and antidepressant medication are efficacious in the treatment of depressive and anxiety disorders, it is not known whether they are equally efficacious for all types of disorders, and whether all types of psychotherapy and antidepressants are equally efficacious for each disorder. We conducted a meta-analysis of studies in which psychotherapy and antidepressant medication were directly compared in the treatment of depressive and anxiety disorders. Systematic searches in bibliographical databases resulted in 67 randomized trials, including 5,993 patients that met inclusion criteria, 40 studies focusing on depressive disorders and 27 focusing on anxiety disorders. The overall effect size indicating the difference between psychotherapy and pharmacotherapy after treatment in all disorders was g=0.02 (95% CI: -0.07 to 0.10), which was not statistically significant. Pharmacotherapy was significantly more efficacious than psychotherapy in dysthymia (g=0.30), and psychotherapy was significantly more efficacious than pharmacotherapy in obsessive-compulsive disorder (g=0.64). Furthermore, pharmacotherapy was significantly more efficacious than non-directive counseling (g=0.33), and psychotherapy was significantly more efficacious than pharmacotherapy with tricyclic antidepressants (g=0.21). These results remained significant when we controlled for other characteristics of the studies in multivariate meta-regression analysis, except for the differential effects in dysthymia, which were no longer statistically significant.
Copyright © 2013 World Psychiatric Association.

Entities:  

Year:  2013        PMID: 23737423      PMCID: PMC3683266          DOI: 10.1002/wps.20038

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  83 in total

1.  Cognitive therapy and pharmacotherapy for depression. Singly and in combination.

Authors:  S D Hollon; R J DeRubeis; M D Evans; M J Wiemer; M J Garvey; W M Grove; V B Tuason
Journal:  Arch Gen Psychiatry       Date:  1992-10

2.  Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy.

Authors:  Kristin Mitte
Journal:  Psychol Bull       Date:  2005-09       Impact factor: 17.737

Review 3.  Uncertainty in heterogeneity estimates in meta-analyses.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Evangelos Evangelou
Journal:  BMJ       Date:  2007-11-03

4.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  A placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.

Authors:  Carlos Blanco; Richard G Heimberg; Franklin R Schneier; David M Fresco; Henian Chen; Cynthia L Turk; Donna Vermes; Brigette A Erwin; Andrew B Schmidt; Harlan R Juster; Raphael Campeas; Michael R Liebowitz
Journal:  Arch Gen Psychiatry       Date:  2010-03

7.  Treatment of bereavement-related major depressive episodes in later life: a controlled study of acute and continuation treatment with nortriptyline and interpersonal psychotherapy.

Authors:  C F Reynolds; M D Miller; R E Pasternak; E Frank; J M Perel; C Cornes; P R Houck; S Mazumdar; M A Dew; D J Kupfer
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

8.  The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes.

Authors:  M M Weissman; B A Prusoff; A Dimascio; C Neu; M Goklaney; G L Klerman
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

9.  Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

Authors:  Jonathan R T Davidson; Edna B Foa; Jonathan D Huppert; Francis J Keefe; Martin E Franklin; Jill S Compton; Ning Zhao; Kathryn M Connor; Thomas R Lynch; Kishore M Gadde
Journal:  Arch Gen Psychiatry       Date:  2004-10

10.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

View more
  111 in total

1.  Dynamic relationships of therapist alliance and group cohesion in transdiagnostic group CBT for anxiety disorders.

Authors:  Peter J Norton; Nikolaos Kazantzis
Journal:  J Consult Clin Psychol       Date:  2015-12-21

2.  Mood matters: a national survey on attitudes to depression.

Authors:  John R Kelly; Mary Cosgrove; Cian Judd; Kathy Scott; Aoibheann Mc Loughlin; Veronica O'Keane
Journal:  Ir J Med Sci       Date:  2019-04-02       Impact factor: 1.568

3.  Adequacy of Depression Treatment in Spouses of Cancer Survivors: Findings From a Nationally Representative US Survey.

Authors:  Kristin Litzelman; Abiola O Keller; Amye Tevaarwerk; Lori DuBenske
Journal:  J Gen Intern Med       Date:  2018-02-05       Impact factor: 5.128

4.  Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder.

Authors:  Yoshihiko Matsumoto; Chiara Fabbri; Silvia Pellegrini; Stefano Porcelli; Pierluigi Politi; Silvio Bellino; Caterina Iofrida; Veronica Mariotti; Erika Melissari; Marco Menchetti; Valentina Martinelli; Marco Cappucciati; Paola Bozzatello; Elena Brignolo; Paolo Brambilla; Matteo Balestrieri; Alessandro Serretti
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

5.  Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder.

Authors:  Sigal Zilcha-Mano; Ulrike Dinger; Kevin S McCarthy; Marna S Barrett; Jacques P Barber
Journal:  J Affect Disord       Date:  2013-10-16       Impact factor: 4.839

6.  Psychotherapy in Contemporary Psychiatric Practice.

Authors:  George Hadjipavlou; Carlos A Sierra Hernandez; John S Ogrodniczuk
Journal:  Can J Psychiatry       Date:  2015-06       Impact factor: 4.356

7.  Further Evidence for Short-Term Psychodynamic Therapy in Major Depressive Disorder.

Authors:  Falk Leichsenring; Christiane Steinert
Journal:  Can J Psychiatry       Date:  2017-01       Impact factor: 4.356

8.  Contemporary Psychiatry, Psychoanalysis, and Psychotherapy.

Authors:  Paula Ravitz
Journal:  Can J Psychiatry       Date:  2017-05       Impact factor: 4.356

Review 9.  Treatment of Depression in Primary Care with Computerized Psychological Therapies: Systematic Reviews.

Authors:  Francisco Rodriguez-Pulido; Gema Castillo; Sofiane Hamrioui; Laura Delgado Martin; Pilar Vazquez-Beltrán; Isabel de la Torre-Díez; Manuel A Franco-Martín
Journal:  J Med Syst       Date:  2020-02-13       Impact factor: 4.460

10.  Increasing intentions to use mental health services among university students. Results of a pilot randomized controlled trial within the World Health Organization's World Mental Health International College Student Initiative.

Authors:  David Daniel Ebert; Marvin Franke; Fanny Kählke; Ann-Marie Küchler; Ronny Bruffaerts; Philippe Mortier; Eirini Karyotaki; Jordi Alonso; Pim Cuijpers; Matthias Berking; Randy P Auerbach; Ronald C Kessler; Harald Baumeister
Journal:  Int J Methods Psychiatr Res       Date:  2018-11-20       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.